Sunrest Lifescience Ltd

SUNREST

Watchlist

AI Mode

‌

Market Cap

₹ 18 Cr

P/E

9.21

‌

‌
‌

‌

‌
‌

Investment Checklist

How to read checklist?

Performance

STEADY PERFORMER

Valuation

REASONABLE

Growth

STABLE

Profitability

HIGH MARGIN

Technicals

Bearish

Risk

HIGH RISK

Investment Checklist

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

Price

PE Ratio

Price

‌

Overview

Detailed Summary

Sunrest Lifescience Limited specializes in marketing OTC generic pharmaceutical products across multiple states in India, such as Maharashtra and Gujarat.

The company recently transitioned from a private to a public entity, marking its ambition for growth and greater market penetration.

Their product portfolio is diverse, covering therapeutic areas like anti-bacterial, anti-diabetic, and nutraceuticals, signaling a broad customer reach.

Sunrest Lifescience relies on Trilend Pharmaceuticals for product manufacturing, emphasizing an integrated group approach to operations.

Sector

Pharmaceuticals

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln M/S

Market Cap

18 Cr

Volatility

High Risk

P/E Ratio

9.2

Industry P/E

30.8

PEG Ratio

0.2

P/B Ratio

1.1

52W High

75.00

52W Low

38.50

Sales CAGR

12.35%

7.20%

24.77%

10Y

—

Profit CAGR

769.57%

37.04%

122.35%

10Y

—

ROE

TTM

10.58%

12.75%

14.95%

10Y

—

ROCE

TTM

11.64%

15.04%

15.63%

10Y

—

Technicals

‌

Forecasts

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
SUNREST	43.00	18 Cr	9.21	1.13	0.00	10.58	11.64	3.48
NORRIS	17.51	18 Cr	—	0.00	0.00	9.68	-17.74	-11.42
CHCL	5.20	13 Cr	—	0.40	0.00	-15.06	2.17	-12.46
BERLDRG	22.70	12 Cr	49.35	1.22	0.00	2.47	7.06	1.32
ORTINGLOBE	13.30	11 Cr	—	8.32	0.00	-73.01	-42.20	-24.80
DECIPHER	9.59	10 Cr	—	0.50	0.00	-42.34	-50.18	-34.13
VIVANZA	2.09	8 Cr	—	1.81	0.00	-6.62	-0.04	-0.62

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Jun 2023
Sales	5.64
Expenses	4.64
Operating Profit	1.00
OPM %	17.73
Other Income	0.00
Interest	0.01
Depreciation	0.02
Profit Before Tax	0.97
Tax %	22.68
Net Profit	0.75
EPS in Rs	—

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	11	17	27	25	29	33
Expenses	11	17	26	22	29	30
Operating Profit	0.15	0.27	1.11	2.90	0.91	3.00
OPM %	1.39	1.62	4.13	11.79	3.08	9.06
Other Income	0.00	0.00	0.02	0.03	0.00	0.00
Interest	0.00	0.01	0.02	0.06	0.22	0.30
Depreciation	0.02	0.04	0.06	0.13	0.10	0.09
Profit Before Tax	0.14	0.22	1.05	2.74	0.59	2.61
Tax %	73.12	25.98	26.02	25.54	61.92	23.33
Net Profit	0.04	0.17	0.78	2.04	0.23	2.00
EPS in Rs	—	—	—	—	—	—
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	0.01	0.01	0.01	3.00	4.29	4.29
Reserves	0.12	0.28	1.06	0.11	9.89	12
Borrowings	2.27	2.32	3.24	2.14	6.16	6.16
Other Liabilities	3.85	6.87	8.71	11	4.81	13
Total Liabilities	6.25	9.48	13	17	25	35
Fixed Assets	0.03	0.15	0.47	0.35	0.26	1.32
CWIP	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.02	0.02	5.52
Other Assets	6.22	9.33	13	16	25	28
Total Assets	6.25	9.48	13	17	25	35

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	-0.90	0.15	-0.44	1.15	-15	1.43
Cash from Investing Activity	-0.01	-0.16	-0.36	-0.03	-0.01	-1.14
Cash from Financing Activity	1.11	0.04	0.90	-1.15	15	-0.30
Net Cash Flow	0.20	0.03	0.11	-0.03	-0.16	-0.01

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Nov 2023	Mar 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Promoters	69.91%	69.91%	69.91%	69.91%	69.91%	69.91%	53.50%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.07%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	30.01%	30.09%	30.09%	30.09%	30.09%	30.09%	46.50%
Total Shareholders	742	580	505	487	459	455	498

Market Transactions

Date	Party	Category	Type	Avg Price (₹)	Total Value (₹)	Quantity	Percent Traded
Nov 13, 2025	Amit r agarwal	Bulk	Buy	49.64	0.26 Cr	52,800	1.23
Nov 13, 2025	Pooja rahul shah	Bulk	Sell	49.64	0.24 Cr	48,000	1.11
Oct 29, 2025	Religo capital advisors priva...	Bulk	Buy	49.93	0.22 Cr	43,200	1.00
Oct 29, 2025	Khushboo ashish jain	Bulk	Sell	50.00	0.21 Cr	41,600	0.96
Sep 23, 2025	Pooja rahul shah	Bulk	Buy	44.00	0.34 Cr	78,400	1.82
Sep 23, 2025	Nikhilkumar yashvntlal thakkar	Bulk	Sell	44.18	0.12 Cr	27,200	0.63
Sep 23, 2025	Bharatkumar vardhilal thakkar	Bulk	Sell	44.00	0.20 Cr	44,800	1.04
Aug 19, 2025	Bharatkumar vardhilal thakkar	Bulk	Sell	52.95	0.17 Cr	32,000	0.74
Aug 04, 2025	Rikhav securities limited	Bulk	Buy	52.00	0.37 Cr	72,000	1.67
Aug 04, 2025	Bhagyesh kiritbhai parekh	Bulk	Sell	52.01	0.22 Cr	43,200	1.00

Projection

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

AI Mode

Oscillators

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Moving Averages

BearishNeutralBullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
SUNREST	43.00	18 Cr	9.21	1.13	0.00	10.58	11.64	3.48
NORRIS	17.51	18 Cr	—	0.00	0.00	9.68	-17.74	-11.42
CHCL	5.20	13 Cr	—	0.40	0.00	-15.06	2.17	-12.46
BERLDRG	22.70	12 Cr	49.35	1.22	0.00	2.47	7.06	1.32
ORTINGLOBE	13.30	11 Cr	—	8.32	0.00	-73.01	-42.20	-24.80
DECIPHER	9.59	10 Cr	—	0.50	0.00	-42.34	-50.18	-34.13
VIVANZA	2.09	8 Cr	—	1.81	0.00	-6.62	-0.04	-0.62

Overview

Detailed Summary

Sunrest Lifescience Limited specializes in marketing OTC generic pharmaceutical products across multiple states in India, such as Maharashtra and Gujarat.

The company recently transitioned from a private to a public entity, marking its ambition for growth and greater market penetration.

Their product portfolio is diverse, covering therapeutic areas like anti-bacterial, anti-diabetic, and nutraceuticals, signaling a broad customer reach.

Sunrest Lifescience relies on Trilend Pharmaceuticals for product manufacturing, emphasizing an integrated group approach to operations.

Sector

Pharmaceuticals

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln M/S

Market Cap

18 Cr

Volatility

High Risk

P/E Ratio

9.2

Industry P/E

30.8

PEG Ratio

0.2

P/B Ratio

1.1

52W High

75.00

52W Low

38.50

Sales CAGR

12.35%

7.20%

24.77%

10Y

—

Profit CAGR

769.57%

37.04%

122.35%

10Y

—

ROE

TTM

10.58%

12.75%

14.95%

10Y

—

ROCE

TTM

11.64%

15.04%

15.63%

10Y

—